Breakwater Investment Management

Position in ABBV — AbbVie Inc.

CIK 2025925 SEATTLE, WA

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$6,794

-$10,387 QoQ

Shares Held

-65.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#4,134

of 4,153 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Breakwater Investment Management holds $137,028 across 12 Drug Manufacturers - General names. ABBV ranks #3 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	59	$70,766
2	JNJ	Johnson & Johnson	169	$42,920
3	ABBV	AbbVie Inc. This page	27	$6,794
4	PFE	Pfizer Inc	259	$6,236
5	NVS	Novartis AG	14	$2,194
6	MRK	Merck & Co., Inc.	16	$2,056
7	AMGN	Amgen Inc	5	$1,810
8	NVO	Novo Nordisk A S	22	$1,054

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,794	27	-65.8%	Shares	Sole	2026-08-06
2026-03-31	$17,181	79	-16.0%	Shares	Sole	2026-05-15
2025-12-31	$21,478	94	0.0%	Shares	Sole	2026-02-02
2025-09-30	$21,764	94	+44.6%	Shares	Sole	2025-10-03
2025-06-30	$12,065	65	0.0%	Shares	Sole	2025-07-09
2025-03-31	$13,618	65	0.0%	Shares	Sole	2025-04-17
2024-12-31	$11,550	65	0.0%	Shares	Sole	2025-01-16
2024-09-30	$12,836	65	-50.4%	Shares	Sole	2025-01-16
2024-06-30	$22,469	131	+101.5%	Shares	Sole	2024-08-08
2024-03-31	$11,836	65	—	Shares	Sole	2024-06-14
No filing history on record for this holder in this stock.